Anzeige
Mehr »
Samstag, 06.09.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40RA7 | ISIN: CA2059531020 | Ticker-Symbol: YU1
Berlin
05.09.25 | 19:10
0,284 Euro
+0,71 % +0,002
1-Jahres-Chart
CONAVI MEDICAL CORP Chart 1 Jahr
5-Tage-Chart
CONAVI MEDICAL CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,1500,41809:40

Aktuelle News zur CONAVI MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.08.Conavi Medical GAAP EPS of -C$0.052
CONAVI MEDICAL Aktie jetzt für 0€ handeln
29.08.Conavi Medical Corp.: Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights371US FDA 510(k) submission remains on track for calendar Q3 2025Successful validation testing of Novasight Hybrid system with key opinion leaders Recent academic publications underscore importance of...
► Artikel lesen
30.07.Conavi Medical Corp: Conavi sees publication of Novasight system case report2
30.07.Conavi Medical Corp.: Novasight Hybrid Imaging System Featured in Published JSCAI Case Report Demonstrating Superior Diagnosis and Precision-Guided Therapy in Complex Coronary Case1
23.07.Conavi Medical Corp: Conavi notes study recommends intracoronary imaging use2
23.07.Conavi Medical Corp.: Conavi Medical Applauds New American Journal of Cardiology Study Highlighting Importance of Intracoronary Imaging During PCI1
18.06.Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) Investor Webinar with Presentation and Audience Q&A1
03.06.Conavi Medical Corp: Conavi Medical grants options to buy 5.84M shares1
03.06.Conavi Medical Corp.: Conavi Medical Announces New Grant of Stock Options1
30.05.Conavi Medical GAAP EPS of -C$0.072
30.05.Conavi Medical Corp.: Conavi Medical Reports Fiscal Q2 2025 Interim Results and Operational Highlights996New U.S. intracoronary imaging guidelines from the American College of Cardiology and recent peer-reviewed research strongly validate Novasight's unique value propositionUpsized $20 million financing...
► Artikel lesen
08.05.Conavi Medical Corp.: Conavi Medical's Novasight Hybrid System Named "Product Innovation of the Year" at 2025 Minnesota Manufacturing Awards1
25.04.Conavi Medical Corp: Conavi Medical investor CPoint acquires 1.87 M shares1
25.04.CPOINT Capital Corp. Announces Changes to Holdings in Conavi Medical Corp.170TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- CPOINT Capital Corp. ("CPOINT") announces that, on April 23, 2025, it and its affiliate Juno Pharmaceuticals LP ("Juno") acquired 1,875,000 common shares...
► Artikel lesen
25.04.Bloom Burton & Co. Inc.: Conavi Medical to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference346Toronto, Ontario--(Newsfile Corp. - April 25, 2025) - Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) ("Conavi" or the "Company"), a commercial stage medical device company focused on designing, manufacturing...
► Artikel lesen
23.04.Conavi Medical Corp: Conavi Medical closes $20-million public offering1
23.04.Conavi Medical Corp. Announces Closing of $20M Public Offering1
18.04.Conavi warns on intravascular catheter issue1
15.04.Conavi Medical Corp: Conavi Medical prices public offering2
02.04.Conavi Medical Corp: Conavi shareholders elect seven directors at AGM1
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1